T. Rowe Price Associates’s KORU Medical Systems KRMD Stock Holding History

T. Rowe Price Associates’s Portfolio KRMD Stock Details KRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$156K	Buy	36,991 +9,955	+37%	+$40.8K	﹤0.01%	3068
2026 Q1	$117K	Hold	27,036	–	–	﹤0.01%	2965
2025 Q4	$158K	Buy	27,036 +5,649	+26%	+$27.1K	﹤0.01%	2862
2025 Q3	$82K	Hold	21,387	–	–	﹤0.01%	2956
2025 Q2	$77K	Buy	+21,387	New	+$60.7K	﹤0.01%	2942
2021 Q3	–	Sell	-14,100	Closed	-$65K	–	2967
2021 Q2	$65K	Sell	14,100 -1,926	-12%	-$7.56K	﹤0.01%	2883
2021 Q1	$56K	Buy	+16,026	New	+$69.4K	﹤0.01%	2819

Other funds holding KRMD

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

TCM

Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Simcoe Capital Spokane, Washington $164M AUM

MIM

Meros Investment Management Dallas, Texas $315M AUM 58.44% 1-Year Est. Return

LCM

Lionhunter Capital Management New York $222M AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

T. Rowe Price Associates's KRMD Position: Q2 2026 in Review

T. Rowe Price Associates increased its KORU Medical Systems (KRMD) stake by 37% in Q2 2026, buying an estimated $40.8K and bringing the position to 36,991 shares worth $156K. The position accounts for ﹤0.01% of the portfolio, ranked #3068.

T. Rowe Price Associates first reported a position in KRMD in Q1 2021 and has held it in 7 quarters since. The position peaked at $158K in Q4 2025. 84 funds tracked by Wall St. Rank hold KRMD as of Q2 2026.

T. Rowe Price Associates held 36,991 shares of KORU Medical Systems worth $156K as of Q2 2026.
T. Rowe Price Associates bought 9,955 KORU Medical Systems shares in Q2 2026, an estimated $40.8K.
KORU Medical Systems made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #3068 holding.
T. Rowe Price Associates first reported a position in KORU Medical Systems in Q1 2021 and has held it in 7 quarters since.
T. Rowe Price Associates's KORU Medical Systems position peaked at $158K in Q4 2025.
84 funds tracked by Wall St. Rank held KORU Medical Systems as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.